Omnicell Inc (OMCL) reports robust Q4 2024 results with significant revenue growth, improved margins, and strategic ...
Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company, will release its fourth-quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback